Literature DB >> 21859386

Comparison of the FXG™: RESP (Asp+) real-time PCR assay with direct immunofluorescence and calcofluor white staining for the detection of Pneumocystis jirovecii in respiratory specimens.

Christine Seah1, Susan E Richardson, George Tsui, Billy Yu, John Thornback, Lisa McTaggart, Andrea Boggild, Nancy L Wengenack, Sean X Zhang.   

Abstract

We compared the FXG™: RESP (Asp +) real-time PCR assay (Myconostica Ltd) with two microscopic staining methods (direct immunofluorescence [IFA] and calcofluor white) for the detection of Pneumocystis jirovecii in 411 respiratory specimens submitted for P. jirovecii examination. We considered the specimen to be microscopically positive if the organism could be visualized through the use of either IFA or calcofluor white. A second, published real-time PCR assay targeting the cdc2 gene of P. jirovecii was used to adjudicate those specimens that were microscopically negative but Myconostica PCR positive. The Myconostica PCR positive samples were deemed to be true positives if they were concordant with microscopically positive results or if they were positive by the second PCR assay. As a result, the Myconostica PCR assay was found to be more sensitive than the two microscopy methods in detecting P. jirovecii (10.5% true positivity rate by PCR, 8.0% by immunofluorescence, and 7.1% by calcofluor white). The Myconostica PCR assay showed 93.5% sensitivity, 95.1% specificity, 70.5% positive predictive value, and 99.1% negative predictive value. Its high negative predictive value suggests a role of the Myconostica PCR assay in ruling out Pneumocystis pneumonia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859386     DOI: 10.3109/13693786.2011.598878

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  4 in total

1.  Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR.

Authors:  Lisa R McTaggart; Nancy L Wengenack; Susan E Richardson
Journal:  J Clin Microbiol       Date:  2012-03-14       Impact factor: 5.948

2.  Evaluation of the Amplex eazyplex Loop-Mediated Isothermal Amplification Assay for Rapid Diagnosis of Pneumocystis jirovecii Pneumonia.

Authors:  Timo Huber; Annerose Serr; Walter Geißdörfer; Christina Hess; Christian Lynker-Aßmus; Friederike D von Loewenich; Christian Bogdan; Jürgen Held
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

3.  Humoral immune responses to Pneumocystis jirovecii antigens in HIV-infected and uninfected young children with pneumocystis pneumonia.

Authors:  Kpandja Djawe; Kieran R Daly; Linda Levin; Heather J Zar; Peter D Walzer
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

4.  Evaluation of a PCR-electrospray ionization mass spectrometry platform for detection and identification of fungal pathogens directly from prospectively collected bronchoalveolar lavage specimens.

Authors:  Bei Jia; Robert Lovari; Heather Miller; David Metzgar; Christian Massire; Heather Carolan; Donna Toleno; Franco D'Alessio; Richard Rothman; Lawrence B Blyn; Sean X Zhang
Journal:  Diagn Microbiol Infect Dis       Date:  2020-01-15       Impact factor: 2.803

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.